Trial
NCT02656849
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Dana-Farber Cancer Institute
Collaborators
Bayer
Condition
Solid Tumor
Intervention
BAY 1000394
Why stopped
Development of BAY1000394 has been terminated by Bayer.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-01